UNSPSC 51282317: Erythromycin ethyl succinate

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1014KSJ86F. European Medicines Agency schedules Erythromycin ethyl succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01942MIG. Erythromycin ethyl succinate generally arises in the molecular formula C43H75NO16. The term 'erythromycin ethyl succinate' is a U.S. Pharmacopeial Convention designation.

Most nations, for tariff and trade purposes, schedule erythromycin ethyl succinate under HS 29415000. SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O.

UNSPSC 51282317 Erythromycin ethyl succinate is a Commodity code that indexes a specific pharmaceutical product, yet the recent state and local opportunities tagged under it do not reflect procurement activity for erythromycin itself. Instead, the tagged solicitations show state and local health and emergency-management agencies sourcing unrelated pharmaceutical and medical products — antimicrobial tablets (doxycycline, ciprofloxacin) and naloxone with drug deactivation systems. State and local governments buying under this code appear to be procuring through piggyback arrangements, cooperative purchasing consortia, and competitive sealed bids. Issuing bodies include state health departments and county public-health authorities responsible for emergency preparedness, disease prevention, and community health distribution.

The recent activity originates from Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392) for doxycycline and ciprofloxacin tablets totaling $2,999,999.11 over the contract life, an Invitation for Bid award. Seminole County, Florida released an IFB on June 30, 2026 (IFB60459723LAS) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries and a response deadline of July 26, 2026. The code shows limited recent activity tied directly to erythromycin ethyl succinate procurement; the opportunities listed reflect a significant mismatch between the Commodity code designation and the products actually being solicited.